Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
5m agoZacks Small-Cap Research Raises FatPipe (NASDAQ:FATN) Valuation from $6.00 to $6.40 per Share Following Preliminary Fiscal Fourth Quarter Business Update
5m agoMEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
5m agoVS Media Enters the AI Smart Living Sector to Explore New Growth Opportunities
32m agoGalderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
32m agoSurface Transforms plc – in Administration, Sale of Business and Assets
Recce Pharmaceuticals Ltd. logo

Recce Pharmaceuticals Ltd.

About

0.48AUD-0.03 -5.94%
Closed • Updated at 17:07 GMT+00:00
Market Cap$104.31M
Volume66.2K
Beta1.07
RSI45.84
Health TechnologyPharmaceuticals: Major

Recce Pharmaceuticals Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 24 2026
Brazil Patent Granted for RECCE Anti-Infectives
Mar 19 2026
RCE Investor Webinar Presentation Deck
Feb 27 2026
Appendix 4D and Interim Financial Report
Feb 2 2026
Recce Enters Second U.S. Department of Defense R&D Agreement
Jan 30 2026
Quarterly Activities/Appendix 4C Cash Flow Report

Community Chat

Ask AI

6ix6ixAIEvents